Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Nov 11;2014(11):CD007879.
doi: 10.1002/14651858.CD007879.pub3.

Hepatitis B vaccination during pregnancy for preventing infant infection

Ussanee S Sangkomkamhang  1 , Pisake Lumbiganon, Malinee Laopaiboon
Affiliations

Hepatitis B vaccination during pregnancy for preventing infant infection

Ussanee S Sangkomkamhang et al. Cochrane Database Syst Rev. .

Abstract

Background: Infant hepatitis B infection increases the risk of chronic infection, cirrhosis or liver cancer (hepatocellular carcinoma) in the adult. Perinatal transmission is a common route of infection.

Objectives: To assess the effectiveness and adverse effects of hepatitis B vaccine administered to pregnant women for preventing hepatitis B virus infection in infants.

Search methods: We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (31 August 2014).

Selection criteria: Randomized controlled trials (RCTs) assessing hepatitis B vaccination compared with placebo or no treatment during pregnancy for preventing infant infection. Quasi-RCTs and cross-over studies were not eligible for inclusion.

Data collection and analysis: Two review authors independently assessed trials for inclusion. If any studies had been included, we planned to assess the risk of bias, extract data and check the data for accuracy of all included studies.

Main results: We did not identify any studies for inclusion.

Authors' conclusions: We found no RCTs that assessed the effects of hepatitis B vaccine during pregnancy for preventing infant infection. Consequently, this review cannot provide guidance for clinical practice in this area. However, it does identify the need for well-designed randomized clinical trials to assess the effect of hepatitis B vaccine during pregnancy on the incidence of infant infection and to determine any adverse effects.

PubMed Disclaimer

Conflict of interest statement

Malinee Laopaiboon received an honorarium from the Thailand Research Fund, a non‐profit organization.This fund partially subsidizes Thai Cochrane reviewers to do and update Cochrane reviews.

Update of

References

References to studies excluded from this review

Gupta 2003 {published data only}
    1. Gupta I, Ratho RK. Immunogenicity and safety of two schedules of Hepatitis B vaccination during pregnancy. Journal of Obstetrics and Gynaecology Research 2003;29(2):84‐6. - PubMed
Li 2003 {published data only}
    1. Li XM, Yang YB, Hou HY, Shi ZJ, Shen HM, Teng BQ, et al. Interruption of HBV intrauterine transmission: a clinical study. World Journal of Gastroenterology 2003;9(7):1501‐3. - PMC - PubMed
Li 2004 {published data only}
    1. Li XM, Shi MF, Yang YB, Shi ZJ, Hou HY, Shen HM, et al. Effect of hepatitis B immunoglobulin on interruption of HBV intrauterine infection. World Journal of Gastroenterology 2004;10(21):3215‐7. - PMC - PubMed
Patwardhan 2005 {published data only}
    1. Patwardhan A, Jamjute P, Peter G. Foetal immunoprophylaxis with hepatitis‐B vaccine could be a cost effective approach towards eradication in the high‐risk population. Journal of Pediatric Gastroenterology and Nutrition 2005;40(5):678.
Wang 2008 {published data only}
    1. Wang FY, Lin P, Zhang HZ. [A randomized controlled trial on effect of hepatitis B immune globulin in preventing hepatitis B virus transmission from mothers to infants]. [Chinese]. Zhonghua Erke Zazhi 2008;46(1):61‐3. - PubMed
Xu 2004 {published data only}
    1. Xu WM, Cui YT, Wang L, Yang H, Liang ZQ, Li M, et al. Efficacy and safety of lamivudine in late pregnancy for the prevention of mother‐child transmission of hepatitis B; a multicentre, randomised, double‐blind, placebo‐controlled study. Hepatology 2004;40(4 Suppl 1):272A‐273A.
Xu 2006 {published data only}
    1. Xu Q, Xiao L, Lu XB, Zhang YX, Cai X. A randomized controlled clinical trial: interruption of intrauterine transmission of hepatitis B virus infection with HBIG. World Journal of Gastroenterology 2006;12(21):3434‐7. - PMC - PubMed
Xu 2009 {published data only}
    1. Xu WM, Cui YT, Wang L, Yang H, Liang ZQ, Li XM, et al. Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double‐blind, placebo‐controlled study. Journal of Viral Hepatitis 2009;16(2):94‐103. - PubMed
Yu 2003 {published data only}
    1. Yu F, Xin QX, Li DR. Clinical observation of blocking HBV intrauterine infection by injection of hepatitis B immunoglobulin before laboring. Clinical Medicine of China 2003;19(11):1049‐50.
Yuan 2006 {published data only}
    1. Yuan J, Lin J, Xu A, Li H, Hu B, Chen J, et al. Antepartum immunoprophylaxis of three doses of hepatitis B immunoglobulin is not effective: a single‐centre randomized study. Journal of Viral Hepatitis 2006;13(9):597‐604. - PubMed
Yue 1999 {published data only}
    1. Yue Y, Yang X, Zhang S. Prevention of intrauterine infection by hepatitis B virus with hepatitis B immune globulin: efficacy and mechanism. Chinese Medical Journal 1999;112(1):37‐9. - PubMed
Zhu 1997 {published data only}
    1. Zhu Q, Lu Q, Gu X, Xu H, Duan S. A preliminary study on interruption of HBV transmission in uterus. Chinese Medical Journal 1997;110:145‐7. - PubMed
Zhu 2003 {published data only}
    1. Zhu Q, Yu G, Yu H, Lu Q, Gu X, Dong Z, et al. A randomized control trial on interruption of HBV transmission in uterus. Chinese Medical Journal 2003;116(5):685‐7. - PubMed

Additional references

Andre 1989
    1. Andre FE. Summary of safety and efficacy data on a yeast derived hepatitis B vaccine. American Journal of Medicine 1989;87(Suppl 3A):14S‐20S. - PubMed
Anonymous 1991
    1. Anonymous. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination: recommendations of the Immunization Practices Advisory Committee (ACIP). Morbidity and Mortality Weekly Report. Recommendations and Reports 1991; Vol. 40, issue RR‐13:1‐25. - PubMed
Assad 1999
    1. Assad S, Francis A. Over a decade of experience with a yeast recombinant hepatitis B vaccine. Vaccine 1999;18(1‐2):57‐67. - PubMed
Beasley 1975
    1. Beasley RP, Stevens CE, Shiao IS, Meng HC. Evidence against breastfeeding as a mechanism for vertical transmission of hepatitis B. Lancet 1975;2(7938):740‐1. - PubMed
Chang 1998
    1. Chang MH. Hepatocellular carcinoma in children. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi 1998;39(6):366‐70. - PubMed
De Lalla 1988
    1. Lalla F, Rinaldi E, Santoro D, Pravettoni G. Immune response to hepatitis B vaccine given at different injection sites and by different routes: a controlled randomized study. European Journal of Epidemiology 1988;4(2):256‐8. - PubMed
Ghendon 1987
    1. Ghendon Y. Perinatal transmission of hepatitis B virus in high‐incidence countries. Journal of Virological Methods 1987;17(1‐2):69‐79. - PubMed
Gitlin 1997
    1. Gitlin N. Hepatitis B: diagnosis, prevention, and treatment. Clinical Chemistry 1997;43(8 Pt 2):1500‐6. - PubMed
GRADE 2008
    1. GRADE [Computer program]. Brozek J, Oxman A, Schünemann H. Version 3.6 for Windows 2008.
Greenberg 1993
    1. Greenberg DP. Pediatric experience with recombinant hepatitis B vaccines and relevant safety and immunization studies. Pediatric Infectious Disease Journal 1993;12(5):438‐45. - PubMed
Grosheide 1993
    1. Grosheide PM, Schalm SW, Os HC, Fetter WP, Heijtink RA. Immune response to hepatitis B vaccine in pregnant women receiving post‐exposure prophylaxis. European Journal of Obstetrics & Gynecology and Reproductive Biology 1993;50(1):53‐8. - PubMed
Higgins 2011
    1. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.
Hollinger 2001
    1. Hollinger FB, Liang TJ. Hepatitis B virus. In: Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA editor(s). Fields Virology. 4th Edition. Philadelphia: Lippincott Williams & Wilkins, 2001:2971‐3036.
Hsieh 1992
    1. Hsieh CC, Tzonou A, Zavitsanos X, Kaklamani E, Lan SJ, Trichopoulos D. Age at first establishment of chronic hepatitis B virus infection and hepatocellular carcinoma risk. A birth order study. American Journal of Epidemiology 1992;136(9):1115‐21. - PubMed
Ingardia 1999
    1. Ingardia CJ, Kelley L, Steinfeld JD, Wax JR. Hepatitis B vaccination in pregnancy: factors influencing efficacy. Obstetrics & Gynecology 1999;93(6):983‐6. - PubMed
Jackson 2007
    1. Jackson Y, Chappuis F, Mezger N, Kanappa K, Loutan L. High immunogenicity of delayed third dose of hepatitis B vaccine in travellers. Vaccine 2007;25(17):3482‐4. - PubMed
Krugman 1981
    1. Krugman S, Holley HP Jr, Davidson M, Simberkoff MS, Matsaniotis N. Immunogenic effect of inactivated hepatitis B vaccine: comparison of 20 microgram and 40 microgram doses. Journal of Medical Virology 1981;8(2):119‐21. - PubMed
Lavanchy 2004
    1. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. Journal of Viral Hepatitis 2004;11(2):97‐107. - PubMed
Levy 1991
    1. Levy M, Koren G. Hepatitis B vaccine in pregnancy: maternal and fetal safety. American Journal of Perinatology 1991;8:227‐32. - PubMed
Mahoney 1993
    1. Mahoney FJ, Woodruff BA, Erben JJ, Coleman PJ, Reid EC, Schatz GC, et al. Effect of a hepatitis B vaccination program on the prevalence of hepatitis B virus infection. Journal of Infectious Diseases 1993;167(1):203‐7. - PubMed
Mahoney 1999
    1. Mahoney FJ, Kane M. Hepatitis B vaccine. In: Plotkin SA, Orenstein WA editor(s). Vaccines. 3rd Edition. Philadelphia: W.B. Saunders Company, 1999:158‐82.
McMahon 1990
    1. McMahon BJ, Alberts SR, Wainwright RB, Bulkow L, Lanier AP. Hepatitis B‐related sequelae. Prospective study in 1400 hepatitis B surface antigen‐positive Alaska Native carriers. Archives of Internal Medicine 1990;150(5):1051‐4. - PubMed
Ngui 1998
    1. Ngui SL, Andrews NJ, Underhill GS, Heptonstall J, Teo CG. Failed postnatal immunoprophylaxis for hepatitis B: characteristics of maternal hepatitis B virus as risk factors. Clinical Infectious Diseases 1998;27(1):100‐6. - PubMed
Parkin 2001
    1. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. International Journal of Cancer 2001;94(2):153‐6. - PubMed
Reddy 1994
    1. Reddy PA, Gupta I, Ganguly NK. Hepatitis‐B vaccination in pregnancy: safety and immunogenic response in mothers and antibody transfer to neonates. Asia‐Oceania Journal of Obstetrics and Gynaecology 1994;20(4):361‐5. - PubMed
RevMan 2014 [Computer program]
    1. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
Safary 2000
    1. Safary A, Beck J. Vaccination against hepatitis B: current challenges for Asian countries and future directions. Journal of Gastroenterology and Hepatology 2000;15(4):396‐401. - PubMed
Schunemann 2009
    1. Schunemann HJ. GRADE: from grading the evidence to developing recommendations. A description of the system and a proposal regarding the transferability of the results of clinical research to clinical practice [GRADE: Von der Evidenz zur Empfehlung. Beschreibung des Systems und Losungsbeitrag zur Ubertragbarkeit von Studienergebnissen]. Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen 2009;103(6):391‐400. - PubMed
Shepard 2006
    1. Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP. Hepatitis B virus infection: epidemiology and vaccination. Epidemiologic Reviews 2006;28:112‐25. - PubMed
Stevens 1985
    1. Stevens CE, Toy PT, Tong MJ, Taylor PE, Vyas GN, Nair PV, et al. Perinatal hepatitis B virus transmission in the United States. Prevention by passive‐active immunization. JAMA 1985;253(12):1740‐5. - PubMed
Wong 1984
    1. Wong VC, Ip HM, Reesink HW, Lelie PN, Reerink‐Brongers EE, Yeung CY, et al. Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis‐B vaccine and hepatitis‐B immunoglobulin. Double‐blind randomised placebo controlled study. Lancet 1984;1(8383):921‐6. - PubMed

References to other published versions of this review

Sangkomkamhang 2011
    1. Sangkomkamhang US, Lumbiganon P, Laopaiboon M. Hepatitis B vaccination during pregnancy for preventing infant infection. Cochrane Database of Systematic Reviews 2011, Issue 3. [DOI: 10.1002/14651858.CD007879.pub2] - DOI - PubMed

Publication types

Substances

LinkOut - more resources